-
1
-
-
0037220149
-
The Science and Politics of Medicines Control
-
Abraham, J. (2003) The Science and Politics of Medicines Control. Drug Safety, 26, pp. 135-143.
-
(2003)
Drug Safety
, vol.26
, pp. 135-143
-
-
Abraham, J.1
-
2
-
-
34248382295
-
Supporting Legislation for Independent Post-marketing (Phase IV) Comparative Evaluation of Pharmaceuticals
-
(2003) Supporting Legislation for Independent Post-marketing (Phase IV) Comparative Evaluation of Pharmaceuticals. APHA Policy Statement 2003-1
-
(2003)
APHA Policy Statement 2003-1
-
-
-
3
-
-
24344465285
-
FDA Standards: Good Enough for Government Work?
-
Avorn, J. (2005) FDA Standards: Good Enough for Government Work?. New England Journal of Medicine, 353, pp. 969-972.
-
(2005)
New England Journal of Medicine
, vol.353
, pp. 969-972
-
-
Avorn, J.1
-
4
-
-
0029066463
-
Incidence of Adverse Drug Events and Potential Adverse Drug Events, Implications for Prevention
-
Bates, D.W., Cullen, D.J., Laird, N., Petersen, L.A., Small, S.D. and Servi, D. (1995) Incidence of Adverse Drug Events and Potential Adverse Drug Events, Implications for Prevention. Journal of American Medical Association, 274, pp. 29-34.
-
(1995)
Journal of American Medical Association
, vol.274
, pp. 29-34
-
-
Bates, D.W.1
Cullen, D.J.2
Laird, N.3
Petersen, L.A.4
Small, S.D.5
Servi, D.6
-
5
-
-
0031012726
-
The Cost of Adverse Events in Hospitalized Patients
-
Bates, D.W., Spell, N., Cullen, D.J., Burdick, E., Laird, N. and Petersen, L.A. (1997) The Cost of Adverse Events in Hospitalized Patients. Journal of American Medical Association, 277, pp. 307-311.
-
(1997)
Journal of American Medical Association
, vol.277
, pp. 307-311
-
-
Bates, D.W.1
Spell, N.2
Cullen, D.J.3
Burdick, E.4
Laird, N.5
Petersen, L.A.6
-
6
-
-
0030896727
-
Reasons for Reporting Adverse Drug Reactions - Some Thoughts Based on an International Review
-
Biriell, D. and Edwards, J.R. (1997) Reasons for Reporting Adverse Drug Reactions-Some Thoughts Based on an International Review. Pharmacoepidemiology Drug Safety, 6, pp. 21-26.
-
(1997)
Pharmacoepidemiology Drug Safety
, vol.6
, pp. 21-26
-
-
Biriell, D.1
Edwards, J.R.2
-
9
-
-
34248391609
-
-
Chikwenya, N., Mtonga, S., Bwembya, M., Andala, R., Chansa, C. and Broms, C. (2004)
-
(2004)
-
-
Chikwenya, N.1
Mtonga, S.2
Bwembya, M.3
Andala, R.4
Chansa, C.5
Broms, C.6
-
10
-
-
0031032055
-
Adverse Events in Hospitalized Patients: Excess Length of Stay, Extra Costs and Attributable Mortality
-
Classen, D.D., Pestonik, S.L., Evans, R.S., Lloyd, J.F. and Burke, J.P. (1997) Adverse Events in Hospitalized Patients: Excess Length of Stay, Extra Costs and Attributable Mortality. Journal of American Medical Association, 277, pp. 301-306.
-
(1997)
Journal of American Medical Association
, vol.277
, pp. 301-306
-
-
Classen, D.D.1
Pestonik, S.L.2
Evans, R.S.3
Lloyd, J.F.4
Burke, J.P.5
-
12
-
-
34248342830
-
-
(2002)
-
(2002)
-
-
-
13
-
-
0035806633
-
Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors
-
DeAngelis, C.D., Fontanarosa, P.B. and Flanagin, A. (2001) Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors. Journal of American Medical Association, 286, pp. 89-91.
-
(2001)
Journal of American Medical Association
, vol.286
, pp. 89-91
-
-
DeAngelis, C.D.1
Fontanarosa, P.B.2
Flanagin, A.3
-
15
-
-
0028049067
-
Harmonisation in Pharmacovigilance
-
Edwards, I.R. and Biriell, C. (1994) Harmonisation in Pharmacovigilance. Drug Safety, 10, pp. 93-102.
-
(1994)
Drug Safety
, vol.10
, pp. 93-102
-
-
Edwards, I.R.1
Biriell, C.2
-
16
-
-
0029838837
-
Can Adverse Drug Reactions be Detected Earlier? A Comparison of Reports by Patients and Professionals
-
Egberts, T.C.G., Smulders, M., De Koning, F.H., Meyboom, R.H. and Leufkens, H.G. (1996) Can Adverse Drug Reactions be Detected Earlier? A Comparison of Reports by Patients and Professionals. British Medical Journal, 313, pp. 530-531.
-
(1996)
British Medical Journal
, vol.313
, pp. 530-531
-
-
Egberts, T.C.G.1
Smulders, M.2
De Koning, F.H.3
Meyboom, R.H.4
Leufkens, H.G.5
-
17
-
-
0027248271
-
Drug Related Hospital Admissions
-
Einarson, T.R. (1993) Drug Related Hospital Admissions. The Annals of Pharmacotherapy, 27, pp. 832-840.
-
(1993)
The Annals of Pharmacotherapy
, vol.27
, pp. 832-840
-
-
Einarson, T.R.1
-
18
-
-
9644302576
-
Postmarketing Surveillance - Lack of Vigilance, Lack of Trust
-
Fontanarosa, P.B., Rennie, D. and DeAngelis, C.D. (2004) Postmarketing Surveillance-Lack of Vigilance, Lack of Trust. Journal of American Medical Association, 292, pp. 2647-2650.
-
(2004)
Journal of American Medical Association
, vol.292
, pp. 2647-2650
-
-
Fontanarosa, P.B.1
Rennie, D.2
DeAngelis, C.D.3
-
19
-
-
33746780482
-
Guidance for Industry: E2E Pharmacovigilance Planning
-
US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
-
(2005) Guidance for Industry: E2E Pharmacovigilance Planning. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.
-
(2005)
-
-
-
20
-
-
25444452228
-
Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemilogic Assessment
-
US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
-
(2005) Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemilogic Assessment. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.
-
(2005)
-
-
-
21
-
-
28644441537
-
Reviewer Guidance: Evaluating Risks of Drug Exposure in Human Pregnancies
-
US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
-
(2005) Reviewer Guidance: Evaluating Risks of Drug Exposure in Human Pregnancies. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research.
-
(2005)
-
-
-
22
-
-
34248389520
-
Structural Injustice and the MDGs: A Critical Analysis of the Zambian Experience
-
Gaynor, C. (2005) Structural Injustice and the MDGs: A Critical Analysis of the Zambian Experience. Trócaire Development Review, pp. 57-84.
-
(2005)
Trócaire Development Review
, pp. 57-84
-
-
Gaynor, C.1
-
23
-
-
34248387082
-
-
(2004) pp. 91-128.
-
(2004)
, pp. 91-128
-
-
-
24
-
-
34248350170
-
-
(2004)
-
(2004)
-
-
-
25
-
-
34248339387
-
-
(2005)
-
(2005)
-
-
-
26
-
-
22144469385
-
The Flight of Physicians from West Africa: Views of African Physicians and Implications for Policy
-
Hagopian, A., Ofosu, A., Fatusi, A., Biritwum, R., Essel, A. and Hart, L.G. (2005) The Flight of Physicians from West Africa: Views of African Physicians and Implications for Policy. Social Science and Medicine, 61, pp. 1750-1760.
-
(2005)
Social Science and Medicine
, vol.61
, pp. 1750-1760
-
-
Hagopian, A.1
Ofosu, A.2
Fatusi, A.3
Biritwum, R.4
Essel, A.5
Hart, L.G.6
-
27
-
-
29144507701
-
Viagra's Rise Above Women's Health Issues: An Analysis of the Social and Political Influences on Drug Approvals in the United States and Japan
-
Hollander, I. (2006) Viagra's Rise Above Women's Health Issues: An Analysis of the Social and Political Influences on Drug Approvals in the United States and Japan. Social Science and Medicine, 62, pp. 683-693.
-
(2006)
Social Science and Medicine
, vol.62
, pp. 683-693
-
-
Hollander, I.1
-
28
-
-
0035912536
-
Lotronex and the FRD: An Erosion of Integrity
-
Horton, R. (2001) Lotronex and the FRD: An Erosion of Integrity. Lancet, 357, pp. 1544-1545.
-
(2001)
Lancet
, vol.357
, pp. 1544-1545
-
-
Horton, R.1
-
32
-
-
34248358423
-
-
Huff-Rousselle, M., Kabwe, V., Nunn, A. and Simooya, O. (2005)
-
(2005)
-
-
Huff-Rousselle, M.1
Kabwe, V.2
Nunn, A.3
Simooya, O.4
-
33
-
-
34248325840
-
-
(2005)
-
(2005)
-
-
-
35
-
-
21844449462
-
The Potential for Interactions Between Antimalarial and Antiretroviral Drugs
-
Khoo, S., Back, D. and Winstanley, P. (2005) The Potential for Interactions Between Antimalarial and Antiretroviral Drugs. AIDS, 19, pp. 995-1005.
-
(2005)
AIDS
, vol.19
, pp. 995-1005
-
-
Khoo, S.1
Back, D.2
Winstanley, P.3
-
36
-
-
34248385466
-
-
Kombe, G., Galaty, D., Mtonga, V. and Banda, P. (2005)
-
(2005)
-
-
Kombe, G.1
Galaty, D.2
Mtonga, V.3
Banda, P.4
-
37
-
-
34248366710
-
FDA Rule Changes in Contention Benefits, Dangers of Shorter Drug Review at Center of Debate
-
Krasner, J. (2002) FDA Rule Changes in Contention Benefits, Dangers of Shorter Drug Review at Center of Debate. The Boston Globe
-
(2002)
The Boston Globe
-
-
Krasner, J.1
-
38
-
-
0036570099
-
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
-
Lasser, K.E., Allen, P.D., Woolnahdler, S.J., Himmelstein, D.U., Wolfe, S.M. and Bor, D.H. (2002) Timing of New Black Box Warnings and Withdrawals for Prescription Medications. Journal of American Medical Association, 287, pp. 2215-2220.
-
(2002)
Journal of American Medical Association
, vol.287
, pp. 2215-2220
-
-
Lasser, K.E.1
Allen, P.D.2
Woolnahdler, S.J.3
Himmelstein, D.U.4
Wolfe, S.M.5
Bor, D.H.6
-
39
-
-
0032522873
-
Incidence of Adverse Drug Reactions in Hospitalized Patients, A Meta Analysis of Prospective Studies
-
Lazarou, J., Pomeraz, B.H. and Corey, P.N. (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients, A Meta Analysis of Prospective Studies. Journal of American Medical Association, 279, pp. 1200-1205.
-
(1998)
Journal of American Medical Association
, vol.279
, pp. 1200-1205
-
-
Lazarou, J.1
Pomeraz, B.H.2
Corey, P.N.3
-
40
-
-
13444311031
-
FDA is Incapable of Protecting US 'Against Another Vioxx'
-
Lenzer, J. (2004) FDA is Incapable of Protecting US 'Against Another Vioxx'. British Medical Journal, 329, p. 1253.
-
(2004)
British Medical Journal
, vol.329
, pp. 1253
-
-
Lenzer, J.1
-
42
-
-
26244465090
-
Antimalarial Treatment with Artemisinin Combination Therapy in Africa
-
Malenga, G., Palmer, A., Staedke, S., Kazadi, W., Mutabingwa, T. and Ansah, E. (2005) Antimalarial Treatment with Artemisinin Combination Therapy in Africa. British Medical Journal, 331, pp. 706-707.
-
(2005)
British Medical Journal
, vol.331
, pp. 706-707
-
-
Malenga, G.1
Palmer, A.2
Staedke, S.3
Kazadi, W.4
Mutabingwa, T.5
Ansah, E.6
-
43
-
-
34248348486
-
-
(2004)
-
(2004)
-
-
-
44
-
-
0033376337
-
Pharmacovigilance in Perspective
-
Meyboom, R.H.B., Egberts, A.C.G., Gribnau, F.W.J. and Hekster, Y.A. (1999) Pharmacovigilance in Perspective. Drug Safety, 21, pp. 429-447.
-
(1999)
Drug Safety
, vol.21
, pp. 429-447
-
-
Meyboom, R.H.B.1
Egberts, A.C.G.2
Gribnau, F.W.J.3
Hekster, Y.A.4
-
45
-
-
0034042841
-
An ABC of Drug Related Problems
-
Meyboom, R.H.B., Lindquist, M. and Egberts, A.C.G. (2000) An ABC of Drug Related Problems. Drug Safety, 22, pp. 415-423.
-
(2000)
Drug Safety
, vol.22
, pp. 415-423
-
-
Meyboom, R.H.B.1
Lindquist, M.2
Egberts, A.C.G.3
-
46
-
-
34248348048
-
-
Ministry of Health
-
(2005) Ministry of Health
-
(2005)
-
-
-
47
-
-
0031941382
-
Frequency and Cost of Serious Adverse Drug Reactions in a Department of General Medicine
-
Moore, N.D., Lecointre, D., Noblet, C. and Mabille, M. (1998) Frequency and Cost of Serious Adverse Drug Reactions in a Department of General Medicine. British Journal of Clinical Pharmacology, 45, pp. 301-308.
-
(1998)
British Journal of Clinical Pharmacology
, vol.45
, pp. 301-308
-
-
Moore, N.D.1
Lecointre, D.2
Noblet, C.3
Mabille, M.4
-
48
-
-
0032565185
-
Adverse Drug Reactions
-
Pirmohamed, M., Breckenridge, A.M., Kitteringham, N.R. and Park, B.K. (1998) Adverse Drug Reactions. British Medical Journal, 316, pp. 1295-1298.
-
(1998)
British Medical Journal
, vol.316
, pp. 1295-1298
-
-
Pirmohamed, M.1
Breckenridge, A.M.2
Kitteringham, N.R.3
Park, B.K.4
-
49
-
-
9644260609
-
Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
-
Psaty, B.M., Furberg, C.D., Ray, W.A. and Weiss, N.S. (2004) Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis. Journal of American Medical Association, 292, pp. 2622-2631.
-
(2004)
Journal of American Medical Association
, vol.292
, pp. 2622-2631
-
-
Psaty, B.M.1
Furberg, C.D.2
Ray, W.A.3
Weiss, N.S.4
-
52
-
-
17444408489
-
The WHO 'Roll Back Malaria Project' Planning for Adverse Event Monitoring in Africa
-
Simooya, O. (2005) The WHO 'Roll Back Malaria Project' Planning for Adverse Event Monitoring in Africa. Drug Safety, 28, pp. 277-286.
-
(2005)
Drug Safety
, vol.28
, pp. 277-286
-
-
Simooya, O.1
-
53
-
-
34248331505
-
-
(2004)
-
(2004)
-
-
-
54
-
-
34248352828
-
-
(2000)
-
(2000)
-
-
-
55
-
-
34248398966
-
-
(2002)
-
(2002)
-
-
-
56
-
-
34248342829
-
-
(2006)
-
(2006)
-
-
-
57
-
-
30444449389
-
Reform of Drug Regulation - Beyond an Independent Drug-Safety Board
-
Wayne, A.W. and Stein, C.M. (2006) Reform of Drug Regulation - Beyond an Independent Drug-Safety Board. New England Journal of Medicine, 354, pp. 194-201.
-
(2006)
New England Journal of Medicine
, vol.354
, pp. 194-201
-
-
Wayne, A.W.1
Stein, C.M.2
-
58
-
-
1942468862
-
Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data
-
Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. and Boddington, E. (2004) Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data. Lancet, 363, pp. 1341-1345.
-
(2004)
Lancet
, vol.363
, pp. 1341-1345
-
-
Whittington, C.J.1
Kendall, T.2
Fonagy, P.3
Cottrell, D.4
Cotgrove, A.5
Boddington, E.6
-
59
-
-
0003312086
-
How a New Policy Led to Seven Deadly Drugs
-
Willman, D. (2000) How a New Policy Led to Seven Deadly Drugs. Los Angeles Times, p. 1.
-
(2000)
Los Angeles Times
, pp. 1
-
-
Willman, D.1
-
60
-
-
0033592242
-
Pharmacovigilance Resources in the United Kingdom
-
Wong, I.C.K. (1999) Pharmacovigilance Resources in the United Kingdom. Pharmaceutical Journal, 7059, pp. 285-288.
-
(1999)
Pharmaceutical Journal
, vol.7059
, pp. 285-288
-
-
Wong, I.C.K.1
-
61
-
-
34248371826
-
-
(1998)
-
(1998)
-
-
-
62
-
-
34248367580
-
-
(2002)
-
(2002)
-
-
-
63
-
-
34248373077
-
-
(2004)
-
(2004)
-
-
-
64
-
-
34248366286
-
-
(2004)
-
(2004)
-
-
|